Keywords: مهار کننده های مونوآمین اکسیداز; Antipsychotic drugs; Drug repurposing; Cancer treatment; Histone deacetylases; Phenothiazines; MSSA; methicillin-susceptible Staphylococus aureus; MRSA; methicillin-resistant; S. SSRIs; selective, serotonin reuptake inhibitors; MAOIs; monoamine oxidase in
مقالات ISI مهار کننده های مونوآمین اکسیداز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده های مونوآمین اکسیداز; 5-Hydroxytryptamine; dopamine antagonists; monoamine oxidase inhibitors; noradrenaline re-uptake inhibitors; norepinephrine; selective serotonin re-uptake inhibitors;
Keywords: مهار کننده های مونوآمین اکسیداز; Tobacco dependence; Monoamine oxidase inhibitors; Tobacco particulate matter; Harman; Norharman;
Keywords: مهار کننده های مونوآمین اکسیداز; Heart failure; Major depression; Oxidative stress; Monoamine oxidase; Monoamine oxidase inhibitors;
Keywords: مهار کننده های مونوآمین اکسیداز; PerÃodo perioperatorio; Desórdenes mentales; Inhibidores de la recaptura de serotonina; Inhibidores de la monoaminooxidasa; Agentes antidepresivos tricÃclicos; Perioperative period; Mental disorders; Serotonin uptake inhibitors; Monoamine oxidase inhib
Keywords: مهار کننده های مونوآمین اکسیداز; Tranylcypromine; Monoamine oxidase inhibitors; Monoamine oxidase; Depression; Depressive disorder; Treatment-resistant;
Keywords: مهار کننده های مونوآمین اکسیداز; Tranylcypromine; Monoamine oxidase inhibitors; Monoamine oxidase; Depression; Depressive disorder; Treatment-resistant;
Keywords: مهار کننده های مونوآمین اکسیداز; Aβ; amyloid β; AA; arachidonic acid; AD; Alzheimer's disease; ALA; α-linolenic acid; APP; amyloid precursor proteins; BDNF; brain-derived neurotrophic factor; CNS; central nervous system; CSF; cerebral spinal fluid; COX2; cyclooxygenase 2; DHA; docosah
Keywords: مهار کننده های مونوآمین اکسیداز; Dopamine antagonists; monoamine oxidase inhibitors; norepinephrine; noradrenaline reuptake inhibitors; 5-hydroxytryptamine; selective serotonin reuptake inhibitors
Keywords: مهار کننده های مونوآمین اکسیداز; ANOVA; Analysis of variance; BPI; Brief Pain Inventory; BLC; Big/Little Circle; DN4; Neuropathic pain in 4 questions; DX; Dextromethorphan; GNT; Graded Naming Test; HAD; Hospital Anxiety and Depression scales; IST; Information Sampling Task; LSEQ; Leeds S
Keywords: مهار کننده های مونوآمین اکسیداز; Antidepressant-like; FDPI; Modified forced swim test; Monoaminergic system; FDPI; 7-fluoro-1,3-diphenylisoquinoline-1-amine; FST; Forced Swimming Test; MAO; Monoamine oxidase; WAY 100635; N-[1]-N-(2-pyridinyl) cyclohexanecarboxamide; 5-HT; serotonin; TCAs
Keywords: مهار کننده های مونوآمین اکسیداز; adult; pain; perioperative period; perioperative care; psychotropic drugs; analgesics; analgesic agents; analgesic drugs; antidepressive agents; antidepressive agents, tricyclic; serotonin uptake inhibitors; monoamine oxidase inhibitors; neurotransmitter
Keywords: مهار کننده های مونوآمین اکسیداز; MDD; major depressive disorder; BD; bipolar disorder; ASA; acetyl-salicylic acid; WHO; World Health Organization; TCAs; tricyclic antidepressants; MAOIs; monoamine oxidase inhibitors; SSRIs; selective serotonin reuptake inhibitors; PAMPs; pathogen associa
Keywords: مهار کننده های مونوآمین اکسیداز; Coumarin; Monoamine oxidase inhibitors; Depression; Alzheimer's disease; Benzopyrones;
Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease
Keywords: مهار کننده های مونوآمین اکسیداز; Alzheimer's disease; Benzo[d]isothiazol-3(2H)-one derivatives; Monoamine oxidase inhibitors; Acetylcholinesterase inhibitors; Aβ aggregation inhibitors; Multifunctional agents;
Design, synthesis and evaluation of 4â²-OH-flurbiprofen-chalcone hybrids as potential multifunctional agents for Alzheimer's disease treatment
Keywords: مهار کننده های مونوآمین اکسیداز; Alzheimer's disease; Flurbiprofen-chalcone hybrids; Multifunctional agents; Monoamine oxidase inhibitors; Aβ aggregation inhibitors; Anti-inflammatory agents;
Acute Stress Persistently Alters Locus Coeruleus Function and Anxiety-like Behavior in Adolescent Rats
Keywords: مهار کننده های مونوآمین اکسیداز; CNS; central nervous system; CRF; corticotropin-releasing factor; EPM; elevated plus maze; fMRI; Functional magnetic resonance imaging; LC; locus coeruleus; MAOIs; monoamine oxidase inhibitors; NE; norepinephrine; OFT; open-field test; PBS; phosphate-buff
Research reportAntidepressant-like effects of ginsenoside Rg2 in a chronic mild stress model of depression
Keywords: مهار کننده های مونوآمین اکسیداز; AMPK; AMP-activated protein kinase; BDNF; brain derived neurotrophic factor; CMS; chronic mild stress; CREB; cAMP response element-binding protein; FST; forced swimming test; GSK3β; glycogen synthase kinase-3β; MAOI; monoamine oxidase inhibitors; NARI;
Involvement of serotonergic, noradrenergic and dopaminergic systems in the antidepressant-like effect of ginsenoside Rb1, a major active ingredient of Panax ginseng C.A. Meyer
Keywords: مهار کننده های مونوآمین اکسیداز; OFT; open-field test; TST; tail suspension test; FST; forced swim test; CUMS; chronic unpredicted mild stress; PCPA; p-Chlorophenylalanine; 5-HTP; 5-hydroxytryptophan; NE; noradrenergic; 5-HT; 5-hydroxytrylamine; 5-HIAA; 5-hydroxyindoleacetic acid; DA; do
Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease
Keywords: مهار کننده های مونوآمین اکسیداز; Monoamine oxidase inhibitors; Acetylcholinesterase inhibitors; Multi-target ligand design; Alzheimer's disease; Coumarin derivatives; AD; Alzheimer's disease; ChEs; Cholinesterases; AChE; Acetylcholinesterase; BuChE; Butyrylcholinesterase; MAO; Monoamine
Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease
Keywords: مهار کننده های مونوآمین اکسیداز; Huntington's disease; Monoamine oxidase; Monoamine oxidase inhibitors; Mouse model; Psychiatric features; Depression; Anxiety; Monoamines;
Research ReportBDNF levels are increased by aminoindan and rasagiline in a double lesion model of Parkinson׳s disease
Keywords: مهار کننده های مونوآمین اکسیداز; Parkinson׳s disease; Dopamine; Norepinephrine; Monoamine oxidase inhibitors; Cognition; Neuroprotection;
α-Ketoamino acid ester derivatives as promising MAO inhibitors
Keywords: مهار کننده های مونوآمین اکسیداز; N-Acetylisatin; α-Ketoamino acid ester; OxymaPure; p-Aminobenzoic acid; Monoamine oxidase inhibitors;
Potent and selective MAO-B inhibitory activity: Amino- versus nitro-3-arylcoumarin derivatives
Keywords: مهار کننده های مونوآمین اکسیداز; 3-Arylcoumarins; Perkin reaction; Monoamine oxidase inhibitors; PAMPA assay; ADME theoretical properties; Docking studies
In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors
Keywords: مهار کننده های مونوآمین اکسیداز; Monoamine oxidase inhibitors; 4-Substituted-7-(halo)benzyloxy-2H-chromene-2-ones; Molecular docking; Selective MAO-B inhibitors; Parkinson's disease; 3D-QSAR
Desmodeleganine, a new alkaloid from the leaves of Desmodium elegans as a potential monoamine oxidase inhibitor
Keywords: مهار کننده های مونوآمین اکسیداز; Monoamine oxidase inhibitors; Desmodium elegans; Alkaloids; Monoamine oxidase
Identification of the stereochemical requirements in the 4-aryl-2-cycloalkylidenhydrazinylthiazole scaffold for the design of selective human monoamine oxidase B inhibitors
Keywords: مهار کننده های مونوآمین اکسیداز; Monoamine oxidase inhibitors; Methylcyclopentane; Diastereoseparation; Molecular modeling; Thiazole
Traitement médicamenteux de la maladie de Parkinson à la phase précoce (de novo et « lune de miel »)
Keywords: مهار کننده های مونوآمین اکسیداز; Maladie de Parkinson; Stratégie thérapeutique; L-Dopa; Agonistes dopaminergiques; IMAO; Parkinson's disease; Therapeutic strategy; Levodopa; Dopamine agonists; Monoamine oxidase inhibitors;
Developing zebrafish models relevant to PTSD and other trauma- and stressor-related disorders
Keywords: مهار کننده های مونوآمین اکسیداز; BDNF; brain-derived neurotrophic factor; COMT; catechol-O-methyltransferase; CRF; corticotropin releasing factor; HTS; high-throughput screens; HPA; hypothalamic-pituitary-adrenal; HPI; hypothalamic-pituitary-interrenal; LSD; lysergic acid diethyl
Flexible and biomimetic analogs of triple uptake inhibitor 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Synthesis, biological characterization, and development of a pharmacophore model
Keywords: مهار کننده های مونوآمین اکسیداز; SSRI; selective serotonin reuptake inhibitors; SNRI; serotonin/norepinephrine reuptake inhibitors; MAO; monoamine oxidase inhibitors; TCA; tricyclic antidepressants; DAT; dopamine transporter; SERT; serotonin transporter; NET; norepinephrine transporters;
Neurogenesis in neurological and psychiatric diseases and brain injury: From bench to bedside
Keywords: مهار کننده های مونوآمین اکسیداز; 6-OHDA; 6-hydroxydopamine; 7-OH-DPAT; 7-hydroxy-N,N-di-n-propyl-2-aminotetralin; AD; Alzheimer's disease; ADAM; a disintegrin and metalloproteinase; APH-1; anterior pharynx-defective 1; ApoE4; apolipoprotein E É4 allele; APP; amyloid precursor protein; A
The discovery of 071031B, a novel serotonin and noradrenaline reuptake inhibitor
Keywords: مهار کننده های مونوآمین اکسیداز; TCAs; tricyclic antidepressants; SSRIs; selective serotonin reuptake inhibitors; NRIs; norepinephrine reuptake inhibitors; SNRIs; serotonin and norepinephrine reuptake inhibitors; NDRIs; norepinephrine and dopamine reuptake inhibitors; MAOI's; monoamine o
Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor
Keywords: مهار کننده های مونوآمین اکسیداز; MDD; major depressive disorder; TCAs; tricyclic antidepressants; MAOIs; monoamine oxidase inhibitors; 5-HT; serotonin; NE; norepinephrine; SSRIs; selective serotonin reuptake inhibitors; NRIs; norepinephrine reuptake inhibitors; SNRIs; serotonin and norep
Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors
Keywords: مهار کننده های مونوآمین اکسیداز; Monoamine oxidase inhibitors; 4-Substituted-7-benzyloxy-2H-chromene-2-ones; Molecular docking; Selective MAO-B inhibitors; Parkinson's disease; Alzheimer's disease; Neurodegenerative diseases;
Monoamine neurocircuitry in depression and strategies for new treatments
Keywords: مهار کننده های مونوآمین اکسیداز; 5-HT; 5-hydroxytryptamine, serotonin; BDNF; brain derived neurotrophic factor; CA; catecholamines; Cg25; subgenual cingulate (Brodmann area 25); CNS; central nervous system; CO-MED; Combining Medications to Enhance Depression Outcomes; CRH; corticotropin-
Antidepressant adverse drug reactions in older adults: Implications for RNs and APNs
Keywords: مهار کننده های مونوآمین اکسیداز; Older adults; Pharmacokinetics; Long term care facility; antidepressants; Selective serotonin reuptake inhibitors; Monoamine oxidase inhibitors; Serotonin norepinephrine inhibitors; Tricyclic; Tetracyclic; Adverse drug reaction
Synthesis and evaluation of aplysinopsin analogs as inhibitors of human monoamine oxidase A and B
Keywords: مهار کننده های مونوآمین اکسیداز; Monoamine oxidase inhibitors; Aplysinopsin analogs; Neurotransmitters; Natural product; Indole alkaloids
Effects of monoamine oxidase Type B inhibitors on motor and non-motor symptoms in Parkinson’s disease: A systematic comparison of rasagiline and selegiline
Keywords: مهار کننده های مونوآمین اکسیداز; Parkinson’s disease; Pharmacotherapy; Monoamine oxidase inhibitors; Selegiline; Rasagiline; Non-motor symptoms
Recent advances in the development of selective human MAO-B inhibitors: (Hetero)arylidene-(4-substituted-thiazol-2-yl)hydrazines
Keywords: مهار کننده های مونوآمین اکسیداز; Hantzsch reaction; Hydrazone; Monoamine oxidase inhibitors; Selective hMAO-B inhibitors; Thiazole
Antidepressants and antipsychotics: anaesthetic implications
Keywords: مهار کننده های مونوآمین اکسیداز; Dopamine antagonists; monoamine oxidase inhibitors; norepinephrine; noradrenaline re-uptake inhibitors; 5-hydroxytryptamine; selective serotonin re-uptake inhibitors
Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity. part 3
Keywords: مهار کننده های مونوآمین اکسیداز; Antidepressants; Pyrido[1,2-c]pyrimidines; Dual 5-HT1A/SERT activity; SERT; serotonin transporter; SAR; structure-activity relationship; 5-HT; serotonin; 8-OH-DPAT; 8-hydroxy-2-(di-n-propylamino)tetraline; Ki; inhibitor constant; TMS; tetramethylsilane; S
Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease
Keywords: مهار کننده های مونوآمین اکسیداز; Banisteriopsis caapi (Spruce ex Griseb.); β-Carboline alkaloids; Proanthocyanidines; HPLC; Monoamine oxidase inhibitors; Antioxidants; Parkinson's disease
Synthesis of new series of quinoxaline based MAO-inhibitors and docking studies
Keywords: مهار کننده های مونوآمین اکسیداز; Quinoxalines; [1,2,4]Triazolo[4,3-a]quinoxalines; Oxidation; Oxidative cyclization; Monoamine oxidase inhibitors
Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease
Keywords: مهار کننده های مونوآمین اکسیداز; Banisteriopsis caapi (Spruce ex Griseb.); β-Carboline alkaloids; Proanthocyanidines; Monoamine oxidase inhibitors; Antioxidants; Parkinson's disease
The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients
Keywords: مهار کننده های مونوآمین اکسیداز; AAIR; atrium paced, atrium sensed inhibited rate modulation; ACC; American College of Cardiology; ACEI; angiotensin converting enzyme inhibitor; ACT; activated clotting time; ADA; American Diabetes Association; AHA; American Heart Association; AMR; antibo
Pharmacological management of unipolar affective disorder
Keywords: مهار کننده های مونوآمین اکسیداز; antidepressants; depression; mood disorders; monoamine oxidase inhibitors; selective serotonin reuptake inhibitors (SSRIs); serotonin and noradrenaline reuptake inhibitors; tricyclic antidepressants
Multifunctional thioxanthone derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease
Keywords: مهار کننده های مونوآمین اکسیداز; Alzheimer's disease; Thioxanthone derivatives; Multifunctional agents; Acetylcholinesterase inhibitors; Anti-Aβ aggregation; Monoamine oxidase inhibitors;
Fluorinated phenylcyclopropylamines
Keywords: مهار کننده های مونوآمین اکسیداز; Cyclopropylamines; Fluorine; Monoamine oxidase inhibitors; Microbial tyramine oxidase; Arthrobacter sp;
The selegiline transdermal system in major depressive disorder: A systematic review of safety and tolerability
Keywords: مهار کننده های مونوآمین اکسیداز; Major depressive disorder; Selegiline transdermal system; Tyramine; Antidepressants; Monoamine oxidase inhibitors; Safety
An Update on Antidepressant Toxicity: An Evolution of Unique Toxicities to Master
Keywords: مهار کننده های مونوآمین اکسیداز; antidepressant toxicity; cyclic antidepressants; selective serotonin reuptake inhibitors; monoamine oxidase inhibitors; atypical antidepressants; serotonin syndrome; alkalinization; MAOI-Food/MAOI-Drug Hypertensive Crisis